Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92930

1.

Favorable outcomes of metformin on coronary microvasculature in experimental diabetic cardiomyopathy.

Abdel-Hamid AAM, Firgany AEL.

J Mol Histol. 2018 Oct 13. doi: 10.1007/s10735-018-9801-4. [Epub ahead of print]

PMID:
30317407
2.

Apical hypertrophic cardiomyopathy: what are the risks in our diverse military population?

Eveson LJ, Williams A.

J R Army Med Corps. 2018 Oct 12. pii: jramc-2018-001017. doi: 10.1136/jramc-2018-001017. [Epub ahead of print]

PMID:
30317215
3.

Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).

Mirabel M, Damy T, Donal E, Huttin O, Labombarda F, Eicher JC, Cervino C, Laurito M, Offredo L, Tafflet M, Jouven X, Giura G, Desnos M, Jeunemaître X, Empana JP, Charron P, Habib G, Réant P, Hagège A; REMY working group of the French Society of Cardiology.

Int J Cardiol. 2018 Sep 28. pii: S0167-5273(18)31463-3. doi: 10.1016/j.ijcard.2018.09.083. [Epub ahead of print]

PMID:
30316646
4.

HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.

Song R, Yang Y, Lei H, Wang G, Huang Y, Xue W, Wang Y, Yao L, Zhu Y.

J Mol Cell Cardiol. 2018 Oct 10. pii: S0022-2828(18)30334-1. doi: 10.1016/j.yjmcc.2018.10.007. [Epub ahead of print]

PMID:
30315806
5.

Stress echo beyond coronary artery disease. is it the holy grail of cardiovascular imaging?

Aggeli C, Polytarchou K, Varvarousis D, Kastellanos S, Tousoulis D.

Clin Cardiol. 2018 Oct 12. doi: 10.1002/clc.23094. [Epub ahead of print] Review.

6.

Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia.

Nuhu F, Bhandari S.

Pharmaceuticals (Basel). 2018 Oct 11;11(4). pii: E103. doi: 10.3390/ph11040103. Review.

7.

Understanding the Etiology of Heart Failure among the Rural Poor in Sub-Saharan Africa: a 10-year Experience from District Hospitals in Rwanda.

Eberly LA, Rusingiza E, Park PH, Ngoga G, Dusabeyezu S, Mutabazi F, Harerimana E, Mucumbitsi J, Nyembo PF, Borg R, Gahamanyi C, Mutumbira C, Ntaganda E, Rusangwa C, Kwan GF, Bukhman G.

J Card Fail. 2018 Oct 9. pii: S1071-9164(18)31066-2. doi: 10.1016/j.cardfail.2018.10.002. [Epub ahead of print]

PMID:
30312764
8.

[Vascular Complications Of Cancer Chemotherapy].

Belenkov YN, Privalova EV, Kozhevnikova MV, Kirichenko YY.

Kardiologiia. 2018 SSep;(S9):4-9. Russian.

PMID:
30312566
9.

Left Ventricular Assist Devices; How Do We Define Success?

Anwer LA, Poddi S, Tchantchaleishvili V, Daly RC, Toeg H, Strand JJ, Stulak JM, Maltais S.

ASAIO J. 2018 Oct 9. doi: 10.1097/MAT.0000000000000894. [Epub ahead of print]

PMID:
30312213
10.

Impact of Diabetes Mellitus on Survival in Patients Bridged-to-Transplantation with Left Ventricular Assist Devices in the United States.

Al-Kindi SG, Al-Suwaidi J, Jayyousi A, Oliveira GH, Khalil CA.

ASAIO J. 2018 Oct 9. doi: 10.1097/MAT.0000000000000896. [Epub ahead of print]

PMID:
30312212
11.

Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.

Giam B, Chu PY, Kuruppu S, Smith AI, Horlock D, Murali A, Kiriazis H, Du XJ, Kaye DM, Rajapakse NW.

Exp Physiol. 2018 Oct 12. doi: 10.1113/EP087189. [Epub ahead of print]

PMID:
30311699
12.

Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach.

Gallagher AM, Lucas R, Cowie MR.

ESC Heart Fail. 2018 Oct 11. doi: 10.1002/ehf2.12363. [Epub ahead of print]

PMID:
30311454
13.

Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Benck L, Kransdorf E, Patel J.

Curr Cardiol Rep. 2018 Oct 11;20(12):131. doi: 10.1007/s11886-018-1077-5. Review.

PMID:
30311008
14.

Can you interpret the ECG under stress?

Sia CH, Singh D, Loh JP.

Singapore Med J. 2018 Sep;59(9):455-459. doi: 10.11622/smedj.2018108.

15.

Retraction Note: Cardiac structural remodeling in hypertensive cardiomyopathy.

Sun SJ, Yao JL, Xu LB, Rui Q, Zhang NN, Chen M, Jiang YF, Yang HJ, Zhou YF.

Hypertens Res. 2018 Oct 11. doi: 10.1038/s41440-018-0097-2. [Epub ahead of print]

PMID:
30310170
16.

[Omental Flap for the Device Infection of the HeartMate II].

Kobayashi K, Kitamura T, Torii S, Mishima T, Ohkubo H, Tanaka Y, Sasahara A, Fukunishi T, Ohtomo Y, Horikoshi R, Murai Y, Miyaji K.

Kyobu Geka. 2018 Oct;71(11):924-928. Japanese.

PMID:
30310003
17.

Prognostic predictive value of TLR4 polymorphisms in Han Chinese population with hypertrophic cardiomyopathy.

Han K, Li YP.

Kaohsiung J Med Sci. 2018 Oct;34(10):569-575. doi: 10.1016/j.kjms.2018.05.004. Epub 2018 Jun 2.

PMID:
30309485
18.

Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.

Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D, Abbate A.

J Am Coll Cardiol. 2018 Oct 16;72(16):1955-1971. doi: 10.1016/j.jacc.2018.07.072. Review.

PMID:
30309474
19.

Searching for Surgical Alternatives in Hypertrophic Cardiomyopathy.

Sorajja P, Katsiyiannis WT, Harris KM.

J Am Coll Cardiol. 2018 Oct 16;72(16):1910-1912. doi: 10.1016/j.jacc.2018.06.077. No abstract available.

PMID:
30309467
20.

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.

Liu L, Li J, Zuo L, Zhang J, Zhou M, Xu B, Hahn RT, Leon MB, Hsi DH, Ge J, Zhou X, Zhang J, Ge S, Xiong L.

J Am Coll Cardiol. 2018 Oct 16;72(16):1898-1909. doi: 10.1016/j.jacc.2018.07.080.

PMID:
30309466

Supplemental Content

Loading ...
Support Center